Literature DB >> 23399781

An in vitro study of the radiobiological effects of flattening filter free radiotherapy treatments.

R B King1, W B Hyland, A J Cole, K T Butterworth, S J McMahon, K M Redmond, C Trainer, K M Prise, C K McGarry, A R Hounsell.   

Abstract

Flattening filter free (FFF) linear accelerators allow for an increase in instantaneous dose-rate of the x-ray pulses by a factor of 2-6 over the conventional flattened output. As a result, radiobiological investigations are being carried out to determine the effect of these higher dose-rates on cell response. The studies reported thus far have presented conflicting results, highlighting the need for further investigation. To determine the radiobiological impact of the increased dose-rates from FFF exposures a Varian Truebeam medical linear accelerator was used to irradiate two human cancer cell lines in vitro, DU-145 prostate and H460 non-small cell lung, with both flattened and FFF 6 MV beams. The fluence profile of the FFF beam was modified using a custom-designed Nylon compensator to produce a similar dose profile to the flattened beam (6X) at the cell surface but at a higher instantaneous dose-rate. For both cell lines there appeared to be no significant change in cell survival. Curve fitting coefficients for DU145 cells irradiated with constant average dose-rates were 6X: α = 0.09 ± 0.03, β = 0.03 ± 0.01 and 6FFF: α = 0.14 ± 0.13, β = 0.03 ± 0.02 with a significance of p = 0.75. For H460 cells irradiated with the same instantaneous dose-rate but different average dose-rate the fit coefficients were 6FFF (low dose-rate): α = 0.21 ± 0.11, 0.07 ± 0.02 and 6FFF (high dose-rate): α = 0.21 ± 0.16, 0.07 ± 0.03, with p = 0.79. The results indicate that collective damage behaviour does not occur at the instantaneous dose-rates investigated here and that the use of either modality should result in the same clinical outcome, however this will require further validation in vivo.

Entities:  

Mesh:

Year:  2013        PMID: 23399781     DOI: 10.1088/0031-9155/58/5/N83

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  15 in total

1.  Impact of flattening-filter-free radiation on the clonogenic survival of astrocytic cell lines.

Authors:  Caroline Steenken; Jens Fleckenstein; Stefan Kegel; Lennart Jahnke; Anna Simeonova; Linda Hartmann; Jens Kübler; Marlon R Veldwijk; Frederik Wenz; Carsten Herskind; Frank Anton Giordano
Journal:  Strahlenther Onkol       Date:  2015-03-13       Impact factor: 3.621

2.  Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.

Authors:  Alba Fiorentino; Niccolò Giaj-Levra; Umberto Tebano; Rosario Mazzola; Francesco Ricchetti; Sergio Fersino; Gioacchino Di Paola; Dario Aiello; Ruggero Ruggieri; Filippo Alongi
Journal:  Radiol Med       Date:  2017-04-26       Impact factor: 3.469

3.  Effect of varying dose-per-pulse and average dose rate in X-ray beam irradiation on cultured cell survival.

Authors:  G Lasio; M Guerrero; W Goetz; F Lima; J E Baulch
Journal:  Radiat Environ Biophys       Date:  2014-08-29       Impact factor: 1.925

4.  Local dose rate effects in implantable cardioverter-defibrillators with flattening filter free and flattened photon radiation.

Authors:  Benjamin Gauter-Fleckenstein; Erol Tülümen; Boris Rudic; Martin Borggrefe; Martin Polednik; Jens Fleckenstein
Journal:  Strahlenther Onkol       Date:  2022-03-10       Impact factor: 4.033

5.  Safety of high-dose-rate stereotactic body radiotherapy.

Authors:  Sonja Stieb; Stephanie Lang; Claudia Linsenmeier; Shaun Graydon; Oliver Riesterer
Journal:  Radiat Oncol       Date:  2015-01-23       Impact factor: 3.481

6.  Establishing stereotactic body radiotherapy with flattening filter free techniques in the treatment of pulmonary lesions - initial experiences from a single institution.

Authors:  Juliane Rieber; Eric Tonndorf-Martini; Oliver Schramm; Bernhard Rhein; Laila König; Sebastian Adeberg; Eva Meyerhof; Angela Mohr; Jutta Kappes; Hans Hoffmann; Jürgen Debus; Stefan Rieken
Journal:  Radiat Oncol       Date:  2016-06-08       Impact factor: 3.481

7.  mARC Treatment of Hypopharynx Carcinoma with Flat and Flattening-Filter-Free Beam Energies - A Planning Study.

Authors:  Katharina Bell; Jochen Fleckenstein; Frank Nuesken; Norbert Licht; Christian Rübe; Yvonne Dzierma
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

8.  Practical approach for pretreatment verification of IMRT with flattening filter free(FFF) beams using Varian Portal Dosimetry.

Authors:  Soonki Min; Young Eun Choi; Jungwon Kwak; Byungchul Cho
Journal:  J Appl Clin Med Phys       Date:  2014-01-08       Impact factor: 2.102

Review 9.  An overview of current practice in external beam radiation oncology with consideration to potential benefits and challenges for nanotechnology.

Authors:  Raymond B King; Stephen J McMahon; Wendy B Hyland; Suneil Jain; Karl T Butterworth; Kevin M Prise; Alan R Hounsell; Conor K McGarry
Journal:  Cancer Nanotechnol       Date:  2017-02-03

10.  Calculated relative biological effectiveness (RBE) for initial DNA double-strand breaks (DSB) from flattening filter and flattening filter-free 6 MV X-ray fields.

Authors:  Hisashi Nakano; Daisuke Kawahara; Satoshi Tanabe; Satoru Utsunomiya; Takeshi Takizawa; Madoka Sakai; Toshimichi Nakano; Atsushi Ohta; Motoki Kaidu; Hiroyuki Ishikawa
Journal:  BJR Open       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.